$51.96
1.09%
NYSE, May 09, 10:19 pm CET
ISIN
US4330001060
Symbol
HIMS

Hims & Hers Health Inc. Stock price

$51.96
+22.47 76.20% 1M
+24.08 86.37% 6M
+27.78 114.89% YTD
+39.04 302.17% 1Y
+48.25 1,300.54% 3Y
+42.06 424.85% 5Y
+42.16 430.20% 10Y
NYSE, Closing price Fri, May 09 2025
+0.56 1.09%
ISIN
US4330001060
Symbol
HIMS
Industry

Key metrics

Market capitalization $11.63b
Enterprise Value $11.37b
P/E (TTM) P/E ratio 75.63
EV/FCF (TTM) EV/FCF 48.33
EV/Sales (TTM) EV/Sales 6.37
P/S ratio (TTM) P/S ratio 6.52
P/B ratio (TTM) P/B ratio 21.15
Revenue growth (TTM) Revenue growth 85.99%
Revenue (TTM) Revenue $1.78b
EBIT (operating result TTM) EBIT $115.57m
Free Cash Flow (TTM) Free Cash Flow $235.27m
Cash position $322.67m
EPS (TTM) EPS $0.69
P/E forward 80.48
P/S forward 4.96
EV/Sales forward 4.85
Short interest 34.61%
Show more

Is Hims & Hers Health Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,793 stocks worldwide.

Hims & Hers Health Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Hims & Hers Health Inc. forecast:

5x Buy
31%
9x Hold
56%
2x Sell
13%

Analyst Opinions

16 Analysts have issued a Hims & Hers Health Inc. forecast:

Buy
31%
Hold
56%
Sell
13%

Financial data from Hims & Hers Health Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,477 1,477
69% 69%
100%
- Direct Costs 320 320
92% 92%
22%
1,156 1,156
64% 64%
78%
- Selling and Administrative Expenses 1,071 1,071
47% 47%
73%
- Research and Development Expense - -
-
-
85 85
455% 455%
6%
- Depreciation and Amortization 17 17
80% 80%
1%
EBIT (Operating Income) EBIT 68 68
303% 303%
5%
Net Profit 126 126
635% 635%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Hims & Hers Health Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hims & Hers Health Inc. Stock News

Positive
Seeking Alpha
about 3 hours ago
Hims & Hers Health rebounded from a 60% stock drop by partnering with Novo Nordisk, offering Wegovy at a competitive price, boosting accessibility and growth. Q1 earnings were exceptional with 111% YoY revenue growth and a 345% increase in net income, highlighting a sustainable and resilient business model. The company's personalized healthcare approach and new product launches, like low testos...
Positive
The Motley Fool
2 days ago
Hims & Hers (NYSE: HIMS) stock has been on fire in 2025, and the company just got more great news after upsizing a $450 million convertible debt offering to up to $1 billion. The growth of Hims & Hers should move overseas, and artificial intelligence will play a bigger role in its future now.
Neutral
Business Wire
3 days ago
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced the pricing of its offering of $870,000,000 aggregate principal amount of 0.00% convertible senior notes due 2030 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as am...
More Hims & Hers Health Inc. News

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Head office United States
CEO Andrew Dudum
Employees 1,637
Founded 2017
Website www.forhims.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today